Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

BUY
$0.39 - $1.69 $2,206 - $9,562
5,658 Added 5.14%
115,826 $45,000
Q3 2022

Nov 15, 2022

BUY
$2.24 - $4.18 $214,141 - $399,603
95,599 Added 656.18%
110,168 $301,000
Q2 2022

Aug 15, 2022

SELL
$2.85 - $7.77 $7,649 - $20,854
-2,684 Reduced 15.56%
14,569 $42,000
Q1 2022

May 13, 2022

BUY
$5.7 - $9.3 $9,969 - $16,265
1,749 Added 11.28%
17,253 $131,000
Q4 2021

Feb 14, 2022

BUY
$8.73 - $15.27 $6,041 - $10,566
692 Added 4.67%
15,504 $135,000
Q1 2021

May 06, 2021

SELL
$26.12 - $52.17 $351,862 - $702,782
-13,471 Reduced 47.63%
14,812 $474,000
Q4 2020

Feb 08, 2021

BUY
$14.05 - $29.0 $18,503 - $38,193
1,317 Added 4.88%
28,283 $697,000
Q3 2020

Nov 12, 2020

BUY
$14.17 - $19.48 $7,453 - $10,246
526 Added 1.99%
26,966 $386,000
Q2 2020

Aug 13, 2020

BUY
$13.25 - $21.72 $5,750 - $9,426
434 Added 1.67%
26,440 $427,000
Q1 2020

May 14, 2020

BUY
$9.73 - $24.9 $710 - $1,817
73 Added 0.28%
26,006 $375,000
Q4 2019

Feb 18, 2020

SELL
$14.22 - $23.38 $2,417 - $3,974
-170 Reduced 0.65%
25,933 $547,000
Q3 2019

Nov 14, 2019

SELL
$22.93 - $41.06 $4,815 - $8,622
-210 Reduced 0.8%
26,103 $599,000
Q2 2019

Aug 14, 2019

BUY
$38.73 - $52.03 $322,427 - $433,149
8,325 Added 46.28%
26,313 $1.06 Million
Q1 2019

May 14, 2019

BUY
$28.11 - $50.77 $2,754 - $4,975
98 Added 0.55%
17,988 $780,000
Q4 2018

Feb 13, 2019

BUY
$26.22 - $56.89 $256,693 - $556,953
9,790 Added 120.86%
17,890 $481,000
Q3 2018

Nov 08, 2018

BUY
$24.31 - $52.74 $19,448 - $42,192
800 Added 10.96%
8,100 $394,000
Q2 2018

Aug 13, 2018

BUY
$20.25 - $35.96 $147,825 - $262,508
7,300 New
7,300 $214,000

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $1.82B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.